InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,692.78
(
-0.37%
)
US TECH 100
19,240.46
(
-0.49%
)
Dow Jones
41,959.30
(
-0.16%
)
Brent Oil
73.84
(
-0.65%
)
Bitcoin
63,222.52
(
0.43%
)
Post# of 43360
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

shajandr

Send PM Follow Ignore
Followers 179
Posts 35707
Boards Moderated 19
Alias Born 04/17/2013

shajandr

Re: None

Sunday, 11/05/2017 1:27:17 AM

Sunday, November 05, 2017 1:27:17 AM

Post# of 43360
Humanigen Is in Talks With Lenders
Humanigen survived a brush with Martin Shkreli, but lost race for FDA voucher
By Peg Brickley
Wall Street Journal
Nov. 1, 2017 2:58 p.m. ET

Humanigen Inc., jailed fraudster Martin Shkreli’s final foray in the pharmaceutical industry, is circling the drain, according to a Securities and Exchange Commission filing Wednesday.

The company is unable to pay lenders that bailed it out of bankruptcy and is in talks about alternative asset-based transactions. Humanigen owes lenders Black Horse Capital LP and Nomis Bay Ltd. $16 million, the SEC filing says.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up